Comma, a female-founded integrated period care startup, announces a $2 million seed funding round.
Comma graduated from the Techstars Physical Health accelerator in 2023, and Techstars venture fund followed on in this latest funding round. More than 50% of Comma’s seed investors are women, which reflects the company’s commitment to prioritizing reproductive health by centering those most impacted at every level.
“People shouldn’t have to choose between a better understanding of their bodies and the threat of surveillance, ” said Miller Morris, founder and CEO of Comma. “That is why we built Comma with security and autonomy at the forefront. Even as policies restricting reproductive rights surface, we remain committed to protecting user data and building community. Consumers deserve better, period.”
Comma is an integrated period care company that combines software, sustainable tampon products, and laboratory diagnostics to bring personalized and predictive medicine to reproductive care. Its flagship product, Sara, is a hyper-secure period tracking app that uses HIPAA-based best practices as a benchmark for its data privacy and security standards. Sara helps users uncover patterns and concerns in their menstrual cycles and connect with relevant care partners.